ReviewFrontiers in oncology2022

Preclinical Models for Acquired Resistance to Third-Generation EGFR Inhibitors in NSCLC: Functional Studies and Drug Combinations Used to Overcome Resistance.

Emna Mahfoudhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.